Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olsalazine for Ankylosing Spondylitis
NCT00004288Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- May 1996
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 2 trial of olsalazine sodium in ankylosing spondylitis (AS), sponsored by National Center for Research Resources. Started May 1996; status: completed.
02
Drugs
olsalazine sodium
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00004288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004288.